SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0000950144-09-004160
Filing Date
2009-05-11
Accepted
2009-05-11 11:03:00
Documents
4
Period of Report
2009-05-11
Filing Date Changed
2009-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g19066e8vk.htm 8-K 8355
2 EX-99.1 g19066exv99w1.htm EX-99.1 85964
3 GRAPHIC g19066g1906602.gif GRAPHIC 3819
4 GRAPHIC g19066g1906601.gif GRAPHIC 7026
  Complete submission text file 0000950144-09-004160.txt   111044
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15875 | Film No.: 09813183
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1